NCT05728749View on ClinicalTrials.gov

A Multicentre, Prospective, Non-interventional Trial Monitoring Therapy Pathways of Asthma Patients Treated With an Extra-fine ICS/LABA/LAMA Single-inhaler Triple Therapy in a Real-world Setting and Characterizing the Effects on Health-related Outcomes

UnknownOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

March 3, 2023

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2025

Conditions
ASTHMA
Interventions
OTHER

Non-interventional

As this is a non-interventional trial, only data obtained within the current routine management of asthma at outpatient respiratory centres or GP centres will be documented.

Trial Locations (1)

92270

RECRUITING

ChiesiFrance, Bois-Colombes

Sponsors

Lead Sponsor

Chiesi SAS
All Listed Sponsors
collaborator

Gesellschaft für Therapieforschung mbH

INDUSTRY

lead

Chiesi SAS

INDUSTRY

NCT05728749 - A Multicentre, Prospective, Non-interventional Trial Monitoring Therapy Pathways of Asthma Patients Treated With an Extra-fine ICS/LABA/LAMA Single-inhaler Triple Therapy in a Real-world Setting and Characterizing the Effects on Health-related Outcomes | Biotech Hunter | Biotech Hunter